Company

Orgenesis Inc.

Headquarters: Germantown, MD, United States

Employees: 111

CEO: Ms. Vered Caplan M.Sc.

NASDAQ: ORGS +0.92%

Market Cap

$13.9 Million

USD as of Jan. 1, 2024

Market Cap History

Orgenesis Inc. market capitalization over time

Evolution of Orgenesis Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Orgenesis Inc.

Detailed Description

Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Orgenesis Inc. has the following listings and related stock indices.


Stock: NASDAQ: ORGS wb_incandescent

Details

Headquarters:

20271 Goldenrod Lane

Germantown, MD 20876

United States

Phone: 480 659 6404